PNPLA3 -associated steatohepatitis: Toward a gene-based classification of fatty liver disease

Seminars in Liver Disease

Volumn 33, Issue 4, 2013, Pages 369-379

  Krawczyk, Marcin ^a   Portincasa, Piero ^b   Lammert, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

adiponutrin; genetic susceptibility; genomics; nonalcoholic steatohepatitis; steatosis

Indexed keywords

ADIPONUTRIN; CHOLESTEROL; GLUCOSE; LIVER ENZYME; PHOSPHOLIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALCOHOL LIVER CIRRHOSIS; ALLELE; ARTICLE; CANCER EPIDEMIOLOGY; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHRONIC LIVER DISEASE; FAT CONTENT; FATTY LIVER; GENE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS B VIRUS; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; OBESITY; PNPLA3 GENE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; ANIMALS; FATTY LIVER; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIPASE; LIPID METABOLISM; LIVER; MEMBRANE PROTEINS; PHENOTYPE; PROGNOSIS; RISK FACTORS;

EID: 84887567748     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0033-1358525     Document Type: Article

References (84)

1. Lazo M., Hernaez R., Eberhardt M. S., et al. Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994. Am J Epidemiol: 2013; 178 1 38 45
2. Blachier M., Leleu H., Peck-Radosavljevic M., Valla D. C., Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol: 2013; 58 3 593 608
3. Vernon G., Baranova A., Younossi Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther: 2011; 34 3 274 285
4. Williams C. D., Stengel J., Asike M. I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology: 2011; 140 1 124 131
5. Chalasani N., Younossi Z., Lavine J. E., et al. American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterologyh. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology: 2012; 142 7 1592 1609
6. Anstee Q. M., Targher G., Day C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol: 2013; 10 6 330 344
7. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology: 2012; 142 4 711 725, e6
8. Sanyal A. J., Brunt E. M., Kleiner D. E., et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology: 2011; 54 1 344 353
9. Sookoian S., Pirola C. J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology: 2011; 53 6 1883 1894
10. Zechner R., Zimmermann R., Eichmann T. O., et al. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab: 2012; 15 3 279 291
11. Huang Y., He S., Li J. Z., et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci U S A: 2010; 107 17 7892 7897
12. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet: 2008; 40 12 1461 1465
13. Mohanty S. R., Troy T. N., Huo D., O'Brien B. L., Jensen D. M., Hart J. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol: 2009; 50 4 797 804
14. Weston S. R., Leyden W., Murphy R., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology: 2005; 41 2 372 379
15. Browning J. D., Szczepaniak L. S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology: 2004; 40 6 1387 1395
16. Yuan X., Waterworth D., Perry J. R., et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet: 2008; 83 4 520 528
17. Chambers J. C., Zhang W., Sehmi J., et al. Alcohol Genome-wide Association (AlcGen) Consortium; Diabetes Genetics Replication and Meta-analyses (DIAGRAM+) Study; Genetic Investigation of Anthropometric Traits (GIANT) Consortium; Global Lipids Genetics Consortium; Genetics of Liver Disease (GOLD) Consortium; International Consortium for Blood Pressure (ICBP-GWAS); Meta-analyses of Glucose and Insulin-Related Traits Consortium (MAGIC). Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet: 2011; 43 11 1131 1138
18. Kotronen A., Johansson L. E., Johansson L. M., et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia: 2009; 52 6 1056 1060
19. Speliotes E. K., Yerges-Armstrong L. M., Wu J., et al. NASH CRN; GIANT Consortium; MAGIC Investigators; GOLD Consortium. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet: 2011; 7 3 e1001324
20. Sookoian S., Castaño G. O., Burgueño A. L., Gianotti T. F., Rosselli M. S., Pirola C. J. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res: 2009; 50 10 2111 2116
21. Valenti L., Al-Serri A., Daly A. K., et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology: 2010; 51 4 1209 1217
22. Rotman Y., Koh C., Zmuda J. M., Kleiner D. E., Liang T. J.; NASH CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology: 2010; 52 3 894 903
23. Anstee Q. M., Darlay R., Leathart J., et al. A candidate-gene approach to validation of genetic modifier association using a large cohort with histologically characterized non-alcoholic fatty liver disease. J Hepatol: 2013; 55 1 S46
24. Krawczyk M., Müllenbach R., Weber S. N., Zimmer V., Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol: 2010; 7 12 669 681
25. Krawczyk M., Grünhage F., Zimmer V., Lammert F. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol: 2011; 55 2 299 306
26. Kawaguchi T., Sumida Y., Umemura A., et al. Japan Study Group of Nonalcoholic Fatty Liver Disease; Takeshi Okanoue. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE: 2012; 7 6 e38322
27. Kitamoto T., Kitamoto A., Yoneda M., et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet: 2013; 132 7 783 792
28. Tian C., Stokowski R. P., Kershenobich D., Ballinger D. G., Hinds D. A. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet: 2010; 42 1 21 23
29. Stickel F., Buch S., Lau K., et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology: 2011; 53 1 86 95
30. Trépo E., Gustot T., Degré D., et al. Common polymorphism in the PNPLA3 /adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol: 2011; 55 4 906 912
31. Müller T., Buch S., Berg T., Hampe J., Stickel F. Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C. J Hepatol: 2011; 55 3 732 733
32. Cai T., Dufour J. F., Muellhaupt B., et al. Swiss Hepatitis C Cohort Study Group. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. J Hepatol: 2011; 55 3 529 535
33. Valenti L., Rumi M., Galmozzi E., et al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology: 2011; 53 3 791 799
34. Trépo E., Pradat P., Potthoff A., et al. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology: 2011; 54 1 60 69
35. Zampino R., Coppola N., Cirillo G., et al. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. J Viral Hepat: 2013; 20 8 517 523
36. Vigano M., Valenti L., Lampertico P., et al. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Hepatology: 2013
37. Trépo E., Guyot E., Ganne-Carrie N., et al. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis. Hepatology: 2012; 55 4 1307 1308
38. Burza M. A., Pirazzi C., Maglio C., et al. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. Dig Liver Dis: 2012; 44 12 1037 1041
39. Hassan M. M., Kaseb A., Etzel C. J., et al. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog: 2013
40. Nischalke H. D., Berger C., Luda C., et al. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS ONE: 2011; 6 11 e27087
41. Takeuchi Y., Ikeda F., Moritou Y., et al. The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol: 2013; 48 3 405 412
42. Liu Y. L., Patman G., Leathart J., et al. Carriage of PNPLA3 I148M is associated with an increases risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol: 2013; 58 1 S516
43. do O N. T., Eurich D., Trautwein C., Neuhaus P., Neumann U. P., Wasmuth H. E. The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C. Hepatology: 2011; 54 4 1483 1484
44. Finkenstedt A., Auer C., Glodny B., et al. PNPLA3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Clin Gastroenterol Hepatol: 2013;; [Epub ahead of print]
45. Valenti L., Alisi A., Galmozzi E., et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology: 2010; 52 4 1274 1280
46. Santoro N., Kursawe R., D'Adamo E., et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology: 2010; 52 4 1281 1290
47. Lin Y. C., Chang P. F., Hu F. C., Yang W. S., Chang M. H., Ni Y. H. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr: 2011; 158 5 740 744
48. Larrieta-Carrasco E., León-Mimila P., Villarreal-Molina T., et al. Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children. Gene: 2013; 520 2 185 188
49. Krawczyk M., Maier I. B., Liebe R., Lammert F., Bergheim I. The common adiponutrin (PNPLA3) variant is associated with subclinical liver injury already in young age: analysis of a cohort of paediatric patients. J Hepatol: 2013; 58 01 S559 S560
50. Marzuillo P., Grandone A., Perrone L., Miraglia Del Giudice E. Weight loss allows the dissection of the interaction between abdominal fat and PNPLA3 (adiponutrin) in the liver damage of obese children. J Hepatol: 2013
51. Romeo S., Sentinelli F., Cambuli V. M., et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol: 2010; 53 2 335 338
52. Palasciano G., Moschetta A., Palmieri V. O., Grattagliano I., Iacobellis G., Portincasa P. Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des: 2007; 13 21 2193 2198
53. Krarup N. T., Grarup N., Banasik K., et al. The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation. PLoS ONE: 2012; 7 7 e40376
54. Krawczyk M., Grünhage F., Mahler M., Tirziu S., Acalovschi M., Lammert F. The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels. J Physiol Pharmacol: 2011; 62 3 369 375
55. Rembeck K., Maglio C., Lagging M., et al. NORDynamIC group PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection. BMC Med Genet: 2012; 13 82
56. Palmer C. N., Maglio C., Pirazzi C., et al. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS ONE: 2012; 7 6 e39362
57. Pirazzi C., Adiels M., Burza M. A., et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J Hepatol: 2012; 57 6 1276 1282
58. Kantartzis K., Peter A., Machicao F., et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes: 2009; 58 11 2616 2623
59. Speliotes E. K., Butler J. L., Palmer C. D., Voight B. F., Hirschhorn J. N.; GIANT Consortium; MIGen Consortium; NASH CRN. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology: 2010; 52 3 904 912
60. Angelico F., Del Ben M., Conti R., et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab: 2005; 90 3 1578 1582
61. Farese R. V. Jr, Zechner R., Newgard C. B., Walther T. C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab: 2012; 15 5 570 573
62. Chen W., Chang B., Li L., Chan L. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology: 2010; 52 3 1134 1142
63. Basantani M. K., Sitnick M. T., Cai L., et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res: 2011; 52 2 318 329
64. Kumari M., Schoiswohl G., Chitraju C., et al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab: 2012; 15 5 691 702
65. Huang Y., Cohen J. C., Hobbs H. H. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem: 2011; 286 43 37085 37093
66. Li J. Z., Huang Y., Karaman R., et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest: 2012; 122 11 4130 4144
67. Greenberg A. S., Coleman R. A., Kraemer F. B., et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest: 2011; 121 6 2102 2110
68. Browning J. D., Cohen J. C., Hobbs H. H. Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease. Hepatology: 2010; 52 4 1189 1192
69. Ratziu V., Cadranel J. F., Serfaty L., et al. A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. J Hepatol: 2012; 57 2 376 383
70. Krawczyk M., Bonfrate L., Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol: 2010; 24 5 695 708
71. Festi D., Schiumerini R., Marzi L., et al. Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods. Aliment Pharmacol Ther: 2013; 37 4 392 400
72. Ludwig J., Viggiano T. R., McGill D. B., Oh B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc: 1980; 55 7 434 438
73. Mirnezami R., Nicholson J., Darzi A. Preparing for precision medicine. N Engl J Med: 2012; 366 6 489 491
74. Valenti L., Dongiovanni P., Ginanni Corradini S., Burza M. A., Romeo S. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease. Dig Liver Dis: 2013; 45 8 619 624
75. Sevastianova K., Kotronen A., Gastaldelli A., et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr: 2011; 94 1 104 111
76. Calamita G., Portincasa P. Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets: 2007; 11 9 1231 1249
77. Petit J. M., Guiu B., Masson D., et al. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes. J Clin Endocrinol Metab: 2010; 95 12 E430 E436
78. Goran M. I., Walker R., Le K. A., et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes: 2010; 59 12 3127 3130
79. Cox A. J., Wing M. R., Carr J. J., et al. Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus. Diabetes Metab: 2011; 37 5 452 455
80. Li Y., Xing C., Tian Z., Ku H. C. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. BMC Med Genet: 2012; 13 113
81. Viganò M., Valenti L., Lampertico P., et al. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Hepatology: 2013
82. Corradini S. G., Burza M. A., Molinaro A., Romeo S. Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma. Hepatology: 2011; 53 5 1776, author reply 1777
83. Falleti E., Fabris C., Cmet S., et al. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int: 2011; 31 8 1137 1143
84. Guyot E., Sutton A., Rufat P., et al. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J Hepatol: 2013; 58 2 312 318